DGKA and asthma: Recently, targeting the diacylglycerol metabolism by DGKζ knockdown or treatment with the DGKα-specific inhibitor R59949 has proven to be beneficial for treating asthma by reducing both inflammation and airway hyperresponsiveness [127].